Healthcare & Medical Devices Global On demand · 24-48h

Global Lateral Flow Assay Test Market Strategic Research Report

Global Lateral Flow Assay Test Market Strategic Research Rep…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Lateral Flow Assay Test Market
$6.14B2025
6.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Sandwich Assays, Competitive Assays

By Application: Medicine, Environment Testing, Food Safety

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher, Becton Dickinson, Abbott, Hologic, Inc., PerkinElmer, Quidel Corporation, Biomérieux, Cytiva (Danaher), Qiagen, Siemens, BUHLMANN, IMMY

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 119 pages
Market size 2025
$6.14B
Billion USD
Forecast CAGR
6.1%
2025-2032
Forecast 2032
$9.3B
Projected
区域
5
Asia Pacific · Latin America · MEA · Europe · North America

概述

Scope of the Report

The global Lateral Flow Assay Test market size is predicted to grow from US$ 6,144 million in 2025 to US$ 9,230 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032.

Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.

Global Lateral Flow Assay Test key players include Thermo Fisher, Becton Dickinson, etc. Global top two manufacturers hold a share nearly 25%. North America is the largest market, with a share over 35%, followed by Europe, Asia-Pacific, both have a share about 55 percent. In terms of product, Sandwich Assays is the largest segment, with a share about 65%. And in terms of application, the largest application is Medicine, followed by Environment Testing, Food Safety, etc.

Lateral Flow Test Industry: Technology-Driven Market Innovation and Enterprise Transformation

The lateral flow test industry, driven by technological iteration, is reshaping the testing paradigm in fields such as medical diagnostics, food safety, and environmental monitoring. Its essence lies in enabling rapid qualitative analysis through simple operation, extending its reach from pathogen detection to contaminant screening, and its application scenarios continue to diversify. Currently, the industry's technological path is shifting from traditional test kits to digital and intelligent devices. The widespread adoption of digital/mobile readers has significantly improved testing efficiency and data traceability, while optimizing test kit sensitivity and specificity has become a key differentiator in competitive competition. This technological evolution not only meets the medical field's demand for immediate point-of-care testing (POCT) but also drives food processing companies to upgrade their capabilities for rapid screening of raw material contamination, creating a virtuous cycle of "technology-application-demand."

Market Dynamics and Growth Logic: Increasing Demand and Policy Resonance

Increasing market demand has become the core driver of industry growth. In the medical sector, from tertiary hospitals to primary care clinics, demand for portable testing equipment has surged, driving the simultaneous expansion of the reagent and instrument markets. In the food industry, under comprehensive "farm-to-table" oversight, companies' investment in rapid testing technology has steadily increased. On the policy front, the government, through documents such as the "Action Plan for Metrology to Support the Development of New Industrial Productivity (2025-2030)," has incorporated metrology technology into strategic support areas, encouraging companies to overcome key technological bottlenecks. Meanwhile, capital markets are significantly increasing their interest in the industry. Research reports from leading brokerages indicate that the lateral flow testing sector is expected to see a boost in both performance and valuation by 2025, driven by favorable policies and liquidity. Internationally competitive companies, in particular, are seizing global market share through cross-border mergers and acquisitions and overseas expansion. Business Outlook: Technological Barriers, Deepening Scenario Development, and Ecosystem Building

Leading companies are consolidating their competitive advantages through three main approaches: First, building technological barriers. For example, Danaher and Bio-Rad have built patent moats in reagent sensitivity and device integration through continuous R&D investment. Second, scenario-based solutions are transitioning from single products to "testing + data services." For example, they offer customized testing packages to hospitals or build full-process traceability systems for food companies. Third, global ecosystem collaboration is fostering collaboration. Leading companies are expanding into international markets through mergers and acquisitions or establishing overseas branches. For example, CICC, leveraging its international presence, has rapidly expanded in Hong Kong equity financing, while China Galaxy Securities is increasing its brokerage market share through its Southeast Asian subsidiary. Furthermore, the integration of technologies like blockchain and the Internet of Things is fostering a closed-loop ecosystem of "testing-data-decision-making." For example, combining test data with blockchain ensures transparency and traceability in the food supply chain.

Future Outlook: Industry Restructuring Driven by Innovation

The future of the lateral flow testing industry belongs to those companies that can transform technological breakthroughs into valuable scenarios. With the deep integration of artificial intelligence, big data, and testing technologies, intelligent testing platforms will become standard, and policy support and capital injection will accelerate industry restructuring. Companies need to leverage "technology + scenarios + ecosystem" as their strategic fulcrum, delving deeply into essential sectors like healthcare, food, and the environment. Simultaneously, through global expansion and ecosystem collaboration, they can upgrade from "testing tool providers" to "industry solution leaders." In this process, those who consistently innovate and accurately understand customer needs will seize the initiative in this technology-driven industrial transformation.

This report presents a comprehensive overview of the global Lateral Flow Assay Test market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Sandwich Assays
  • Competitive Assays

Segment by players, this report covers

  • Thermo Fisher
  • Becton Dickinson
  • Abbott
  • Hologic, Inc.
  • PerkinElmer
  • Quidel Corporation
  • Biomérieux
  • Cytiva (Danaher)
  • Qiagen
  • Siemens
  • BUHLMANN
  • IMMY

Segment by Application

  • Medicine
  • Environment Testing
  • Food Safety

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Lateral Flow Assay Test market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Medicine, Environment Testing, Food Safety evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Lateral Flow Assay Test Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$6.14B
2025
Forecast
$9.3B
2032
CAGR
6.1%
2025–2032
区域
5
global
Key companies
Thermo FisherBecton DickinsonAbbottHologic, Inc.PerkinElmerQuidel CorporationBiomérieuxCytiva (Danaher)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Sandwich AssaysCompetitive Assays
By Application
MedicineEnvironment TestingFood Safety

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Sandwich Assays
  • 3.1.3 Competitive Assays
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Medicine
  • 4.1.3 Environment Testing
  • 4.1.4 Food Safety
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Becton Dickinson
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Abbott
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Hologic, Inc.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 PerkinElmer
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Quidel Corporation
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Biomérieux
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Cytiva (Danaher)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Qiagen
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Siemens
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 BUHLMANN
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 IMMY
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Lateral Flow Assay Test market?
The global Lateral Flow Assay Test market is estimated at US$ 6.14 billion in 2025 (base year) and is projected to reach US$ 9.23 billion by 2032.
How fast is the Lateral Flow Assay Test market expected to grow?
The market is expected to grow at a CAGR of 6.1% from 2026 to 2032, expanding from US$ 6.14 billion in 2025 to US$ 9.23 billion in 2032, roughly 1.5 times its base-year value.
What does the Lateral Flow Assay Test market cover?
Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.
What are the main segments of the Lateral Flow Assay Test market by type?
By type, the market is segmented into Sandwich Assays and Competitive Assays.
Which applications drive demand in the Lateral Flow Assay Test market?
Key applications covered include Medicine, Environment Testing and Food Safety.
Who are the key players in the Lateral Flow Assay Test market?
Key players profiled include Thermo Fisher, Becton Dickinson, Abbott, Hologic, PerkinElmer, Quidel Corporation, Biomérieux and Cytiva (Danaher), among 12 companies covered in total.
Which regions and countries are covered for Lateral Flow Assay Test?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Lateral Flow Assay Test market?
Lateral Flow Test Industry: Technology-Driven Market Innovation and Enterprise Transformation
What challenges does the Lateral Flow Assay Test market face?
On the policy front, the government, through documents such as the "Action Plan for Metrology to Support the Development of New Industrial Productivity (2025-2030)," has incorporated metrology technology into strategic support areas, encouraging companies to overcome key technological bottlenecks.
Who should buy the Lateral Flow Assay Test market report?
The report is intended for manufacturers and solution providers, distributors and end users in Medicine, Environment Testing and Food Safety, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Lateral Flow Assay Test market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.